Botox 200 unit vials

Ended Awarded

Contract number
SPE2DB25FR1JN
Awardee
Awarding agency
Obligated
$6,469

Award facts

Contract value 100% obligated
$6,468.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $6,468.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities.

DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its specialized focus on delivering branded and generic prescription drugs, biologics, and medical consumables to military health systems. The company's contract portfolio with the DLA demonstrates consistent success in securing delivery orders for high-value pharmaceutical products, including specialty medications for oncology and other therapeutic areas. This particular delivery order for Botox reflects the vendor's ongoing role in fulfilling the DoD's pharmaceutical procurement needs across its healthcare network.

Quick answers

Who was awarded contract SPE2DB25FR1JN?

SPE2DB25FR1JN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.

How much is contract SPE2DB25FR1JN worth?

The government has obligated $6,469 on SPE2DB25FR1JN.

Is contract SPE2DB25FR1JN an order under another contract?

Yes. SPE2DB25FR1JN is a delivery order under SPE2DB22D9251, an indefinite delivery contract.

Was contract SPE2DB25FR1JN competed?

The extent of competition for SPE2DB25FR1JN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award